Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT06203912 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Dexamethasone
PROCEDURE: Echocardiography
BIOLOGICAL: Isatuximab
OTHER: Questionnaire Administration
BIOLOGICAL: Universal Donor Expanded TGF-beta-imprinted NK Cells

Sponsor

Elvira Umyarova

Collaborators

[object Object]